These findings suggest that a complex regulatory network of CBX1-associated miRNAs is involved in the pathogenesis of liver disease and key cancer-related processes, underscoring their potential significance as biomarkers and therapeutic targets in LIHC. The gene discussed is CBX1; the disease is cancer.